News
This means is that if a company is charging ‘X’ for a particular medicine in a particular country and charging ‘2X’ in the US ...
Capital Market on MSN44m
Solara Active Pharmas Ambernath facility clears USFDA inspectionCommenting on the inspection outcome, Sandeep Rao, MD & CEO said, "We are very happy with the successful inspection outcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback